One of the guiding principles of Cystic Fibrosis Canada’s Strategic Plan is to ensure that our work resonates with the Canadian cystic fibrosis (CF) community. That is why, in advance of our Research Grants & Awards Competition last year, we worked with our community to determine your top priorities when it comes to cystic fibrosis research.
When we launched our Grants and Awards Competition last fall, we asked that the applicants provide us research proposals on these priority topics. To evaluate these research proposals and fund the best science, we’ve always had a lengthy review process that includes written critiques by international CF experts, written reviews by a panel of Canadian and US CF experts, and an in-person discussion by that panel on the scientific merits of the applications. For the past several years we also included one CF patient and one CF parent among the reviewers. This ensured that we funded only the best science and had a little perspective from the community.
This year the COVID-19 pandemic forced us to hold our three days of review meetings virtually rather than in person. And this provided a unique opportunity: we no longer had to limit community reviewers to one CF patient and one CF parent.
We put out a call to Elevate, our community consultation program, to request volunteer community reviewers. The role was to work alongside our scientific reviewers to help us determine not only the best scientific proposals but ensure that they aligned with the priorities of our community and would have the potential for positive benefits to those in Canada with cystic fibrosis. The response exceeded our expectations!